Are you gearing up for product launches and health technology assessment (HTA) submissions? Look no further! EVERSANA is proud to announce an exclusive course at the ISPOR Education Center, led by renowned experts Chris Cameron from EVERSANA and Brian Hutton from Ottawa Hospital Research Institute and University of Ottawa. This course is designed to provide professionals with invaluable insights and practical experience in optimizing ITC strategies for global programs.
Why You Should Register
Indirect Treatment Comparisons (ITC) are crucial for meeting international evidence requirements and ensuring successful HTA program launches. This course zeroes in on the practicalities of launching global ITC programs, covering various methodologies including network meta-analysis, matching adjusted indirect treatment comparisons, simulated treatment comparison, external control arm studies, and multilevel network meta-regression (ML-NMR).
Participants will delve into the feasibility assessments of ITCs, evaluating the viability and potential impact of different ITC methodologies. You’ll learn about the selection process to match specific HTA requirements, including the nuances related to ITC submission requirements by global HTA bodies and recent EU-HTA initiatives. Navigating through the complexities of evidence requirements, this course ensures that your ITC program meets the rigorous standards set forth by these organizations.
Learning Objectives
- Discuss the various ITC methodologies and compare and contrast their strengths and limitations.
- Explain the nuances of global evidence requirements and how they shape the selection of ITC methods for HTA submissions.
- Develop a comprehensive evidence-generation plan that aligns with international standards and optimizes the chances of successful HTA program launches.
- Utilize the knowledge of ITC feasibility assessments to make informed decisions in the planning and execution of global ITC programs.
Don’t miss this opportunity to learn from the best in the field. Register now and elevate your expertise in ITC strategies for global programs. Gain practical experience and insights to navigate global evidence requirements and optimize your ITC programs.
Register now or contact us to learn more.
Author
Dr. Chris Cameron is a global thought leader in health economics and outcomes research with over a decade of experience. Prior to joining EVERSANA, Chris was a partner at Cornerstone Research Group Inc., and…